Stocks / MNPR
Stock profile · 銘柄

Monopar Therapeutics Inc. - Common Stock (MNPR)

Monopar Therapeutics Inc. - Common Stock (MNPR) last closed at $104.50 (as of 2026-07-09). On Shishin's four-engine momentum model it scored 64/100, flagged by the Suzaku engine (Extended) on its most recent scan appearance (2026-07-10). It has surfaced in 1 daily scan since 2026-07-10. The figures below are research data, the Shishin Score and the momentum, trend, and volatility indicators the engines observe, not investment advice.

Price updates daily; the engine read reflects MNPR's most recent scan appearance. Shishin's live daily signals are published each morning on the rankings board.

Shishin Score64
Active engineSuzaku
SetupExtended
Current close$104.50
SectorBiotechnology
Price · last ~60 sessions
$104.503/64/177/9
Indicators · as of 2026-07-10
ADR · 20d7.8%
ATR · 146.4%
RSI · 1482
Return · 30d+67%
Return · 60d+86%
Above MA2029%
Above MA5052%
Range · 20d94%
MA stack3
From 52w high-7%
$ Vol · 30d$9M
Vol ratio2.50×
Frequently asked

What is MNPR's Shishin momentum score?

As of 2026-07-10, MNPR scores 64/100 on Shishin's four-engine composite, flagged by the Suzaku engine. The score blends momentum, trend, and volatility indicators on a 0 to 100 scale.

Is MNPR showing a momentum setup?

MNPR's current setup state is "Extended." This describes what the engines observe in the chart structure, it is a data classification, not a recommendation to buy or sell.

Which Shishin engine flags MNPR?

Most recently the Suzaku engine. Each of the four guardians is tuned for a different market regime.

How often has MNPR appeared in Shishin scans?

MNPR has appeared in 1 daily scan since 2026-07-10. Recurring appearances indicate a persistent setup; one-off appearances are more transient.

How is the Shishin Score calculated?

The Shishin Score (0 to 100) is a weighted blend of momentum (multi-horizon returns), trend (moving-average stack, distance from MAs), and volatility/liquidity (ADR, ATR, dollar volume) indicators, scored per the engine active for the current market regime.

Related reading

Research data, not investment advice. Shishin publishes what its systematic engines observe; it does not recommend buying or selling any security, and is not a registered investment adviser or broker-dealer. See our risk disclosure.

Today's full rankings →5-year track record →More Biotechnology momentum stocks →More Suzaku setups →All covered stocks →